Summary
A new piperidine derivative, the 2-diphenylmethylpiperidine, produces already in doses of 0.001 g/kg s.c. a strong increase of the spontaneous motility of various animals. On mice it has about the same potency as d-desoxy-ephedrine and is about 3 times more potent than amphetamin. It also acts markedly antagonistic on various narcotics but has practically no peripheral sympathomimetic effects.
References
L. Panizzon, Helv. chim. Acta27, 1748 (1944);29, 324 (1946).
R. Meier, F. Gross undJ. Tripod, Klin. Wschr.32, 445 (1954).
l. Mitteilung über Alkylenimin-Derivate,E. Tagmann, E. Sury undK. Hoffmann, Helv. chim. Acta35, 1235 (1952).
Unabhängig von uns haben vor kurzemB. B. Brown undH. W. Werner [Fed. Proc.12, 1003 (1953); J. Pharmacol.110, 180 (1954)] mitgeteilt, dass ein Derivat dieser Reihe, nämlich das 2-(Diphenyloxy-methyl)-piperidin, eine zentralerregende Wirkung vom Amphetamintypus besitze.
J. Tripod, Helv. physiol. Acta10, 403 (1952).
F. Hauschild, Arch. exp. Path. Pharm.191, 465 (1939).
Author information
Authors and Affiliations
Additional information
8. Mitteilung über Alkylenimin-Derivate. 7. Mitteilung sieheB. M. Iselin undK. Hoffmann, J. Am. Chem. Soc.76 (im Druck).
Rights and permissions
About this article
Cite this article
Tripod, J., Sury, E. & Hoffmann, K. Zentralerregende Wirkung eines neuen Piperidinderivates. Experientia 10, 261–262 (1954). https://doi.org/10.1007/BF02157398
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02157398